Authors: | Vermaat, J. S.; Pals, S. T.; Younes, A.; Dreyling, M.; Federico, M.; Aurer, I.; Radford, J.; Kersten, M. J. |
Article Title: | Precision medicine in diffuse large B-cell lymphoma: Hitting the target |
Keywords: | signal transduction; cancer chemotherapy; treatment response; gene mutation; lestaurtinib; prednisone; cancer recurrence; sorafenib; doxorubicin; drug efficacy; rituximab; outcome assessment; dna damage; unindexed drug; cancer immunotherapy; bortezomib; gene expression profiling; editorial; cyclophosphamide; vincristine; immunoglobulin enhancer binding protein; high throughput screening; dasatinib; carcinogenesis; cancer genetics; protein bcl 10; tipifarnib; protein bcl 6; large cell lymphoma; medicine; myeloid differentiation factor 88; toll like receptor; enzastaurin; carfilzomib; molecularly targeted therapy; phase 2 clinical trial (topic); phase 3 clinical trial (topic); phase 1 clinical trial (topic); growth factor receptor; b lymphocyte receptor; vemurafenib; pacritinib; ruxolitinib; idelalisib; pictilisib; ibrutinib; buparlisib; human; precision medicine; sotrastaurin; fostamatinib; rigosertib |
Journal Title: | Haematologica |
Volume: | 100 |
Issue: | 8 |
ISSN: | 0390-6078 |
Publisher: | Ferrata Storti Foundation |
Date Published: | 2015-08-03 |
Start Page: | 989 |
End Page: | 993 |
Language: | English |
DOI: | 10.3324/haematol.2015.128371 |
PROVIDER: | scopus |
PUBMED: | 26314080 |
PMCID: | PMC5004412 |
DOI/URL: | |
Notes: | Export Date: 2 September 2015 -- Source: Scopus |